ChartRow logo
ChartRow
Stocks and ETFs

financial statements

The full income statement, balance sheet, and cash-flow statement for Charles River Laboratories (CRL), plus valuation ratios — straight from SEC filings. Switch between annual, quarterly, and trailing-twelve-month figures, pick how far back to look, and flip the time order. Every line has a trend sparkline.

See the live CRL chart & snapshot →

As-reported fiscal years.
Line itemTrendFY2025FY2024FY2023FY2022FY2021
Income Statementas ofDec 27 ’25as ofDec 28 ’24as ofDec 30 ’23as ofDec 31 ’22as ofDec 25 ’21
Revenue
4.02B
YoY-0.9%
4.05B
YoY-1.9%
4.13B
YoY+3.9%
3.98B
YoY+12.3%
3.54B
YoY+21.1%
Selling, general & administrative
743M
YoY-1.1%
751M
YoY+0.4%
748M
YoY+12.4%
665M
YoY+7.3%
620M
YoY+17.2%
Restructuring
99.8M
YoY-6.7%
107M
YoY+260.4%
29.7M
YoY+261.4%
8.21M
YoY+19.8%
6.86M
YoY-45.6%
Amortization of intangibles
179M
YoY+29.3%
138M
YoY+0.8%
137M
YoY-6.2%
147M
YoY+17.4%
125M
YoY+11.6%
Provision for credit losses
6.06M
YoY-59.0%
14.8M
YoY-18.9%
18.2M
YoY+171.8%
6.71M
YoY+304.7%
1.66M
YoY-74.0%
Operating income
25.2M
YoY-88.9%
227M
YoY-63.2%
617M
YoY-5.2%
651M
YoY+10.4%
590M
YoY+36.3%
Interest expense
107M
YoY-15.3%
126M
YoY-7.6%
137M
YoY+130.6%
59.3M
YoY-19.8%
73.9M
YoY-14.5%
Interest & investment income
4.94M
YoY-42.4%
8.57M
YoY+65.0%
5.20M
YoY+566.2%
780K
YoY+19.6%
652K
YoY-21.8%
Other non-operating income
-22.6M
YoY-36.7%
-16.5M
YoY-117.3%
95.5M
YoY+213.0%
30.5M
YoY+185.0%
-35.9M
YoY-135.9%
Pre-tax income
-99.5M
YoY-206.9%
93.1M
YoY-84.0%
581M
YoY-6.7%
623M
YoY+29.6%
481M
YoY+7.5%
Income tax
42.7M
YoY-37.1%
67.8M
YoY-32.8%
101M
YoY-22.6%
130M
YoY+59.2%
81.9M
YoY+0.1%
-144M
YoY-750.1%
22.2M
YoY-95.3%
475M
YoY-2.4%
486M
YoY+24.4%
391M
YoY+7.3%
-$2.91
YoY-1555.0%
$0.20
YoY-97.8%
$9.22
YoY-2.7%
$9.48
YoY+24.7%
$7.60
YoY+5.6%
Balance Sheetas ofDec 27 ’25as ofDec 28 ’24as ofDec 30 ’23as ofDec 31 ’22as ofDec 25 ’21
1.45B
YoY+3.1%
1.40B
YoY-12.8%
1.61B
YoY+11.8%
1.44B
YoY+12.9%
1.27B
YoY+6.1%
7.14B
YoY-5.2%
7.53B
YoY-8.1%
8.20B
YoY+7.8%
7.60B
YoY+8.2%
7.02B
YoY+27.9%
1.12B
YoY+12.7%
994M
YoY-5.8%
1.06B
YoY-3.3%
1.09B
YoY+5.7%
1.03B
YoY+23.0%
3.92B
YoY-2.4%
4.02B
YoY-11.4%
4.54B
YoY-0.9%
4.58B
YoY+3.3%
4.43B
YoY+32.4%
3.16B
YoY-8.6%
3.46B
YoY-3.8%
3.60B
YoY+20.9%
2.98B
YoY+17.4%
2.53B
YoY+19.9%
Cash Flowas ofDec 27 ’25as ofDec 28 ’24as ofDec 30 ’23as ofDec 31 ’22as ofDec 25 ’21
738M
YoY+0.4%
735M
YoY+7.4%
684M
YoY+10.4%
620M
YoY-18.6%
761M
YoY+39.2%
-209M
YoY+14.6%
-245M
YoY+56.5%
-563M
YoY+7.4%
-608M
YoY+57.7%
-1.44B
YoY-139.0%
-537M
YoY+2.6%
-551M
YoY-544.2%
-85.5M
YoY-101.7%
-42.4M
YoY-106.3%
673M
YoY+1323.5%
FX effect on cash
18.8M
YoY+207.7%
-17.5M
YoY-317.2%
8.04M
YoY-68.6%
25.6M
YoY+44.3%
17.7M
YoY+2133.0%
Net change in cash
10.4M
YoY+113.2%
-78.9M
YoY-282.4%
43.3M
YoY+948.4%
-5.10M
YoY-138.7%
13.2M
YoY+290.5%
Interest paid
102M
YoY-17.6%
123M
YoY-6.5%
132M
YoY+31.1%
101M
YoY+42.4%
70.8M
YoY-2.3%
Income taxes paid
120M
YoY-5.1%
126M
YoY+39.5%
90.4M
YoY+19.1%
75.9M
YoY+0.6%
75.4M
YoY+25.6%
Valuation Ratiosas ofDec 27 ’25as ofDec 28 ’24as ofDec 30 ’23as ofDec 31 ’22as ofDec 25 ’21
Market cap
10.0B
YoY+5.3%
9.52B
YoY-21.5%
12.1B
YoY+9.4%
11.1B
YoY-40.5%
18.6B
YoY+48.8%
P/E
22.7×
YoY-11.1%
25.5×
YoY+0.5%
25.4×
YoY-45.9%
46.9×
YoY+13.1%
P/S
2.5×
YoY+5.2%
2.4×
YoY-17.7%
2.9×
YoY-1.9%
2.9×
YoY-46.0%
5.4×
YoY+22.7%
P/B
2.9×
YoY+15.8%
2.5×
YoY-30.7%
3.7×
YoY-13.1%
4.2×
YoY-45.0%
7.7×
YoY+16.3%
P/FCF
18.4×
YoY+7.5%
17.1×
YoY-47.9%
32.9×
YoY-17.0%
39.6×
YoY-3.7%
41.2×
YoY+46.9%
Earnings yield
4.4%
YoY+12.5%
3.9%
YoY-0.5%
3.9%
YoY+84.7%
2.1%
YoY-11.6%
FCF yield
5.4%
YoY-7.0%
5.8%
YoY+91.8%
3.0%
YoY+20.5%
2.5%
YoY+3.9%
2.4%
YoY-31.9%
Source filing10-K10-K10-K10-K10-K

About this data

Source: CRL's SEC filings (10-K / 10-Q). Annual columns are as-reported fiscal years; quarterly columns are as-reported fiscal quarters (Q4 derived as full-year minus the first three quarters where a company doesn't file a standalone Q4); TTM (quarterly) rolls the trailing four quarters at every quarter end, TTM (yearly) samples that one year apart; balance-sheet rows show the period-end balance. Valuation ratios are sampled as of each period end. View all CRL filings on SEC EDGAR → Not investment advice.